Effects of insulin-like growth factor-I administration on in vivo regulation of urea synthesis in normal subjects and patients with cirrhosis.
Sandahl
Thomas D
TD
Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark. thomas.damgaard.sandahl@ki.au.dk
Aagaard
Niels K
NK
Thomsen
Karen L
KL
Grøfte
Thorbjørn
T
Greisen
Jacob
J
Christiansen
Jens S
JS
Vilstrup
Hendrik
H
D000328:Adult; D000409:Alanine / Q000008:administration & dosage; D018592:Cross-Over Studies; D003718:Denmark; D005260:Female; D005934:Glucagon / Q000097:blood; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D018969:Insulin-Like Growth Factor Binding Proteins / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000008:administration & dosage*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008104:Liver Cirrhosis, Alcoholic / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D015990:Placebo Effect; D013997:Time Factors; D016896:Treatment Outcome; D014508:Urea / Q000378:metabolism*
D018969:Insulin-Like Growth Factor Binding Proteins; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; D014508:Urea; D005934:Glucagon; D000409:Alanine